The Announcement That Reshuffled Workplace Drug Policy
Published June 1, 2021 — By Ann Karim, Senior Cannabis Editor
- Amazon announced in June 2021 it would stop pre-employment cannabis drug testing for most positions.
- The company committed to reinstating employees previously terminated for positive cannabis tests.
- Amazon publicly backed the MORE Act, federal legislation to decriminalize cannabis nationally.
- The decision was driven partly by severe labor shortages: 1.4 million unfilled US jobs in mid-2021.
- Approximately 27% of US workers were subject to pre-employment cannabis testing at the time.
- The move accelerated a broader employer trend toward removing cannabis from drug panels in legal states.
What Amazon Actually Changed
In June 2021, Amazon’s HR leadership published an announcement that became one of the most significant workplace cannabis policy developments in US history. The company — employing approximately 950,000 Americans at the time — stated it would no longer screen most job applicants for marijuana use in pre-employment drug testing. Beyond that, Amazon committed to reinstating employees dismissed for failing cannabis tests — an acknowledgment that its prior policy had caused unnecessary hardship.
The policy change applied to hourly workers including warehouse associates and delivery drivers, with carve-outs for safety-sensitive positions subject to federal Department of Transportation requirements. The announcement was notable not just for its scale but for its lobbying commitment: Amazon explicitly stated it would support the MORE Act to decriminalize cannabis and expunge prior convictions. One of America’s largest private employers was now actively lobbying for federal cannabis reform.
The decision was framed around two converging realities: the changing legal landscape as more US states legalized recreational cannabis, and brutal labor market conditions with over 1.4 million unfilled positions. Requiring cannabis abstinence in a tight labor market, particularly in states where recreational use was fully legal, was cutting Amazon off from a substantial portion of the available workforce in a moment when labor competition was at historic levels.
“We have found that eliminating pre-employment testing for marijuana allows us to expand our applicant pool while ensuring we maintain the highest safety standards on the job.” — Amazon, June 2021
The Broader Employer Trend
Amazon’s announcement accelerated a shift already building. In states like New York, Colorado, and California, growing numbers of employers had quietly removed cannabis from pre-employment drug panels as legalization expanded. Amazon’s move added unprecedented corporate muscle to the trend, signaling to mid-size and smaller employers that dropping cannabis testing was not just legally permissible but strategically sound in competitive labor markets.
HR industry surveys conducted in months following Amazon’s announcement found a measurable uptick in employers reviewing or eliminating cannabis testing requirements. The practical driver was clear: standard urine tests detect cannabis metabolites for up to 30 days after use, meaning a legal recreational user could fail a Monday morning pre-employment test after weekend use — a policy outcome that made decreasing sense as drug test science evolved and legal frameworks diversified across states.
Federal Legalization Lobbying: A New Corporate Front
Amazon’s decision to publicly lobby for the MORE Act represented something genuinely new in the federal cannabis debate. Cannabis industry companies had long advocated for federal legalization out of obvious commercial self-interest. Amazon had no such direct interest — it was a logistics and technology company advocating for cannabis reform as a workforce policy position. This gave its advocacy a different political character that resonated with legislators skeptical of industry-funded cannabis lobbying.
The MORE Act’s journey through Congress remained complex, but Amazon’s vocal support kept federal reform on the legislative agenda. For advocates tracking US cannabis law reform at the federal level, Amazon’s June 2021 intervention demonstrated that the corporate constituency for cannabis reform extended well beyond the cannabis industry itself — a meaningful shift in the political landscape surrounding what had long been a stalled federal debate.
What It Means for Cannabis Users
For millions of Americans who use cannabis legally in their states but had faced employment barriers due to testing policies, Amazon’s move was practically significant and symbolically important. The principle that legal recreational cannabis use in off-hours should not disqualify a worker from employment gained its most powerful corporate endorsement to date. As more employers follow, the gap between state-level legalization rights and practical employment consequences for cannabis users began to narrow in meaningful ways that the legal framework alone had been unable to accomplish.